<DOC>
	<DOC>NCT00630682</DOC>
	<brief_summary>The purpose of this study is to assess the safety and effectiveness dextroamphetamine to help methamphetamine users quit or cut down on their use. The study lasts for 9 weeks. Eligible participants will attend research visits twice per week, and will receive individual counseling sessions once per week for all 9 weeks. 50% of the participants will receive the active medication while the other 50% will receive the placebo (sugar pill). Neither the participant or the study team will know if the participant is receiving the placebo or active drug.</brief_summary>
	<brief_title>A Pilot Trial of Dextroamphetamine for Methamphetamine Dependence</brief_title>
	<detailed_description />
	<mesh_term>Behavior, Addictive</mesh_term>
	<mesh_term>Methamphetamine</mesh_term>
	<mesh_term>Dextroamphetamine</mesh_term>
	<criteria>1850 yrs. old pregnant or lactating females Contact site for additional information</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Methamphetamine</keyword>
	<keyword>Drug Abuse</keyword>
	<keyword>Drug Treatment</keyword>
	<keyword>Addiction</keyword>
	<keyword>Meth</keyword>
	<keyword>Treatment for Methamphetamine Dependence</keyword>
</DOC>